NCT01415167

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Study Contact:

Study Phase:

Recruitment Status:

COMPLETED

NCT ID:

NCT01415167

Principal Investigator:

Study Type:

OBSERVATIONAL

Official Title:

Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Summary

The purpose of this registry is to collect information on patients who are receiving treatment with Proleukin in an organized way, and to learn more about patient care during and after treatment.

Eligibility

Inclusion Criteria:

* 18 years or older
* Must have received at least one course of high dose IL-2 or Proleukin
* Signed informed consent form

Exclusion Criteria:

* Prior high dose IL-2 or Proleukin therapy

Disease(s) and\or Condition(s)

Metastatic Renal Cell Carcinoma

Metastatic Melanoma

Primary Purpose

Intervention/Treatment

Sponsor

Prometheus Laboratories